25
Participants
Start Date
January 13, 2020
Primary Completion Date
February 20, 2020
Study Completion Date
February 20, 2020
HIP1601 40mg
Single dosing of HIP1601 40mg, PO
Seoul National University Biomedical Research Institute, Seoul
Lead Sponsor
Hanmi Pharmaceutical Company Limited
INDUSTRY